Angel Lee, PDG de PhytoHealth, récompensé pour sa contribution au développement du premier médicament sur ordonnance au monde destiné à traiter la fatigue liée au cancer

RegulatoryapprovedPG2®Positive

AI Analysis

Summary

Angel Lee, CEO of PhytoHealth, was recognized for his contribution to developing PG2®, the first new herbal medicine approved in Taiwan for treating cancer-related fatigue. The award highlights PhytoHealth's work in drug development and raising healthcare professional awareness about cancer-related fatigue.

Outcome Details

First new herbal medicine approved in Taiwan

Importance:5/10

Sentiment:

0.70

Taiwanherbal medicineregulatory approvalcancer-related fatiguePhytoHealth

Read the original article

Published by PR Newswire Biotech on October 2, 2026 9:48 AM

Read Original